Provectus Biopharmaceuticals Inc (PVCT)
0.1964
0.00 (0.00%)
USD |
OTCM |
Apr 25, 16:00
Provectus Biopharmaceuticals Market Cap: 82.39M for April 25, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 25, 2024 | 82.39M |
| April 24, 2024 | 81.39M |
| April 23, 2024 | 81.72M |
| April 22, 2024 | 81.72M |
| April 19, 2024 | 81.72M |
| April 18, 2024 | 81.81M |
| April 17, 2024 | 79.71M |
| April 16, 2024 | 75.47M |
| April 15, 2024 | 70.27M |
| April 12, 2024 | 70.23M |
| April 11, 2024 | 76.31M |
| April 10, 2024 | 71.19M |
| April 09, 2024 | 67.12M |
| April 08, 2024 | 60.65M |
| April 05, 2024 | 62.51M |
| April 04, 2024 | 64.29M |
| April 03, 2024 | 67.08M |
| April 02, 2024 | 73.25M |
| April 01, 2024 | 79.75M |
| March 28, 2024 | 76.71M |
| March 27, 2024 | 83.90M |
| March 26, 2024 | 82.65M |
| March 25, 2024 | 83.90M |
| March 22, 2024 | 79.96M |
| March 21, 2024 | 83.07M |
| Date | Value |
|---|---|
| March 20, 2024 | 83.86M |
| March 19, 2024 | 82.86M |
| March 18, 2024 | 83.90M |
| March 15, 2024 | 90.98M |
| March 14, 2024 | 84.91M |
| March 13, 2024 | 86.74M |
| March 12, 2024 | 89.61M |
| March 11, 2024 | 85.39M |
| March 08, 2024 | 83.38M |
| March 07, 2024 | 89.44M |
| March 06, 2024 | 71.32M |
| March 05, 2024 | 70.63M |
| March 04, 2024 | 70.77M |
| March 01, 2024 | 66.28M |
| February 29, 2024 | 62.38M |
| February 28, 2024 | 61.27M |
| February 27, 2024 | 60.83M |
| February 26, 2024 | 60.29M |
| February 23, 2024 | 59.59M |
| February 22, 2024 | 60.79M |
| February 21, 2024 | 59.57M |
| February 20, 2024 | 59.38M |
| February 16, 2024 | 58.29M |
| February 15, 2024 | 56.95M |
| February 14, 2024 | 57.22M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
12.31M
Minimum
Mar 20 2020
90.98M
Maximum
Mar 15 2024
32.86M
Average
27.09M
Median
Aug 06 2019
Market Cap Benchmarks
| Insmed Inc | 3.700B |
| NeuroMetrix Inc | 8.760M |
| Intra-Cellular Therapies Inc | 6.983B |
| Rhythm Pharmaceuticals Inc | 2.294B |
| Amylyx Pharmaceuticals Inc | 120.65M |
Market Cap Related Metrics
| Price | 0.1964 |
| Earnings Yield | -2.96% |